肝脏血管瘤(hemangioma of the liver)是婴幼儿时期最常见的肝脏良性实体肿瘤,多发于女孩。其虽属良性病变,大多生长缓慢,但仍有潜在的危险性。进展迅速者可出现顽固性心力衰竭、消耗性凝血功能障碍、肝脏破裂等而致死~([1-2])。随着医学的进步,其治疗思维及治疗手段已呈多元化发展,本文就小儿肝脏血管瘤的治疗进展作一综述。一、病因与病理小儿肝脏血管瘤发病机制尚未明确,有研究表 Hemangioma of the liver is the most common solid tumor of the liver in infancy. It occurs frequently in girls. Although its benign lesions, most of them grow slowly, but there are still potential dangers. Rapid progress can be refractory heart failure, consumption of coagulation disorders, liver rupture and death ~ ([1-2]). With the progress of medicine, the treatment of thinking and treatment has shown a diversified development, this article reviews the progress of treatment of pediatric hepatic hemangiomas. First, the etiology and pathology The pathogenesis of pediatric liver hemangioma is not yet clear, there are studies